CalciMedica, Historical Financial Ratios

CALC Stock

3.22 0.07 2.13%

CalciMedica, Common is presently reporting on over 83 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.49 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate CalciMedica, Common Stock financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About CalciMedica, Financial Ratios Analysis

CalciMedica, Common StockFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CalciMedica, Common investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CalciMedica, financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CalciMedica, Common history.

CalciMedica, Common Financial Ratios Chart

At present, CalciMedica, Common's PB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Income Quality is expected to grow to 0.97, whereas Book Value Per Share is forecasted to decline to 1.98.

Ptb Ratio Book Value Per Share Pb Ratio Payables Turnover

Add Fundamental

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Most ratios from CalciMedica, Common's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CalciMedica, Common Stock current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
PB Ratio	0.25	1.57	1.42	1.49
Capex To Depreciation	6.66	1.34	1.55	1.47

Pb Ratio Capex To Depreciation

CalciMedica, Common fundamentals Correlations

	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield	Net Debt To E B I T D A
Ptb Ratio		-0.44	0.69	0.76	-0.45	1.0	0.76	-0.68	0.78	0.85	-0.8	-0.3	-0.45	-0.86	-0.72	0.62	-0.87	0.18	-0.31	-0.93	0.29	-0.9	-0.94	0.28	0.76	0.24
Book Value Per Share	-0.44		-0.75	-0.73	-0.26	-0.44	-0.71	0.72	-0.24	-0.67	0.25	0.2	1.0	0.38	0.21	0.03	0.38	-0.27	0.45	0.59	0.46	0.42	0.6	0.46	-0.74	0.39
Free Cash Flow Yield	0.69	-0.75		1.0	-0.35	0.69	0.99	-0.42	0.73	0.96	-0.74	0.05	-0.75	-0.85	-0.77	0.3	-0.85	0.45	-0.77	-0.62	0.18	-0.84	-0.65	0.17	0.99	0.25
Operating Cash Flow Per Share	0.76	-0.73	1.0		-0.38	0.76	1.0	-0.46	0.78	0.98	-0.78	0.0	-0.73	-0.89	-0.8	0.35	-0.89	0.44	-0.74	-0.68	0.21	-0.88	-0.71	0.21	0.99	0.28
Capex To Depreciation	-0.45	-0.26	-0.35	-0.38		-0.45	-0.41	-0.28	-0.54	-0.43	0.55	-0.37	-0.26	0.62	0.71	-0.81	0.64	0.08	0.33	0.16	-0.62	0.61	0.18	-0.61	-0.34	-0.6
Pb Ratio	1.0	-0.44	0.69	0.76	-0.45		0.76	-0.68	0.78	0.85	-0.8	-0.3	-0.45	-0.86	-0.72	0.62	-0.87	0.18	-0.31	-0.93	0.29	-0.9	-0.94	0.28	0.76	0.24
Free Cash Flow Per Share	0.76	-0.71	0.99	1.0	-0.41	0.76		-0.45	0.78	0.98	-0.78	0.02	-0.72	-0.89	-0.81	0.37	-0.89	0.43	-0.74	-0.68	0.22	-0.89	-0.71	0.22	0.99	0.28
Roic	-0.68	0.72	-0.42	-0.46	-0.28	-0.68	-0.45		-0.24	-0.52	0.27	0.55	0.73	0.35	0.12	-0.18	0.35	-0.02	-0.06	0.89	0.39	0.44	0.87	0.38	-0.5	0.44
Inventory Turnover	0.78	-0.24	0.73	0.78	-0.54	0.78	0.78	-0.24		0.81	-1.0	-0.23	-0.25	-0.94	-0.88	0.31	-0.93	0.65	-0.66	-0.59	0.62	-0.88	-0.64	0.61	0.75	0.69
Net Income Per Share	0.85	-0.67	0.96	0.98	-0.43	0.85	0.98	-0.52	0.81		-0.82	0.0	-0.67	-0.93	-0.84	0.45	-0.93	0.36	-0.64	-0.77	0.29	-0.94	-0.8	0.29	0.99	0.31
Days Of Inventory On Hand	-0.8	0.25	-0.74	-0.78	0.55	-0.8	-0.78	0.27	-1.0	-0.82		0.23	0.25	0.96	0.9	-0.35	0.95	-0.6	0.61	0.63	-0.61	0.91	0.67	-0.6	-0.75	-0.67
Payables Turnover	-0.3	0.2	0.05	0.0	-0.37	-0.3	0.02	0.55	-0.23	0.0	0.23		0.19	0.06	-0.17	0.25	0.05	-0.44	-0.03	0.44	0.32	0.03	0.43	0.32	0.05	0.24
Cash Per Share	-0.45	1.0	-0.75	-0.73	-0.26	-0.45	-0.72	0.73	-0.25	-0.67	0.25	0.19		0.38	0.22	0.03	0.38	-0.26	0.44	0.6	0.44	0.42	0.61	0.44	-0.75	0.38
Pocfratio	-0.86	0.38	-0.85	-0.89	0.62	-0.86	-0.89	0.35	-0.94	-0.93	0.96	0.06	0.38		0.95	-0.52	1.0	-0.42	0.6	0.7	-0.54	0.99	0.74	-0.53	-0.87	-0.57
Interest Coverage	-0.72	0.21	-0.77	-0.8	0.71	-0.72	-0.81	0.12	-0.88	-0.84	0.9	-0.17	0.22	0.95		-0.52	0.95	-0.33	0.54	0.52	-0.69	0.94	0.56	-0.69	-0.8	-0.71
Capex To Operating Cash Flow	0.62	0.03	0.3	0.35	-0.81	0.62	0.37	-0.18	0.31	0.45	-0.35	0.25	0.03	-0.52	-0.52		-0.55	-0.47	0.02	-0.48	0.26	-0.59	-0.48	0.26	0.35	0.14
Pfcf Ratio	-0.87	0.38	-0.85	-0.89	0.64	-0.87	-0.89	0.35	-0.93	-0.93	0.95	0.05	0.38	1.0	0.95	-0.55		-0.4	0.6	0.71	-0.54	0.99	0.75	-0.53	-0.87	-0.56
Days Payables Outstanding	0.18	-0.27	0.45	0.44	0.08	0.18	0.43	-0.02	0.65	0.36	-0.6	-0.44	-0.26	-0.42	-0.33	-0.47	-0.4		-0.75	-0.11	0.24	-0.29	-0.15	0.23	0.39	0.44
Income Quality	-0.31	0.45	-0.77	-0.74	0.33	-0.31	-0.74	-0.06	-0.66	-0.64	0.61	-0.03	0.44	0.6	0.54	0.02	0.6	-0.75		0.14	-0.25	0.5	0.19	-0.24	-0.68	-0.42
Roe	-0.93	0.59	-0.62	-0.68	0.16	-0.93	-0.68	0.89	-0.59	-0.77	0.63	0.44	0.6	0.7	0.52	-0.48	0.71	-0.11	0.14		0.0	0.77	1.0	0.0	-0.7	0.05
Ev To Operating Cash Flow	0.29	0.46	0.18	0.21	-0.62	0.29	0.22	0.39	0.62	0.29	-0.61	0.32	0.44	-0.54	-0.69	0.26	-0.54	0.24	-0.25	0.0		-0.49	-0.04	1.0	0.22	0.97
Pe Ratio	-0.9	0.42	-0.84	-0.88	0.61	-0.9	-0.89	0.44	-0.88	-0.94	0.91	0.03	0.42	0.99	0.94	-0.59	0.99	-0.29	0.5	0.77	-0.49		0.8	-0.48	-0.88	-0.48
Return On Tangible Assets	-0.94	0.6	-0.65	-0.71	0.18	-0.94	-0.71	0.87	-0.64	-0.8	0.67	0.43	0.61	0.74	0.56	-0.48	0.75	-0.15	0.19	1.0	-0.04	0.8		-0.04	-0.73	0.0
Ev To Free Cash Flow	0.28	0.46	0.17	0.21	-0.61	0.28	0.22	0.38	0.61	0.29	-0.6	0.32	0.44	-0.53	-0.69	0.26	-0.53	0.23	-0.24	0.0	1.0	-0.48	-0.04		0.22	0.97
Earnings Yield	0.76	-0.74	0.99	0.99	-0.34	0.76	0.99	-0.5	0.75	0.99	-0.75	0.05	-0.75	-0.87	-0.8	0.35	-0.87	0.39	-0.68	-0.7	0.22	-0.88	-0.73	0.22		0.26
Net Debt To E B I T D A	0.24	0.39	0.25	0.28	-0.6	0.24	0.28	0.44	0.69	0.31	-0.67	0.24	0.38	-0.57	-0.71	0.14	-0.56	0.44	-0.42	0.05	0.97	-0.48	0.0	0.97	0.26

Click cells to compare fundamentals

CalciMedica, Common Account Relationship Matchups

CalciMedica, Common fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Ptb Ratio	0.0291	0.14	0.25	1.57	1.42	1.49
Book Value Per Share	200.5	42.94	23.43	1.82	2.09	1.98
Free Cash Flow Yield	(11.98)	(3.62)	(2.8)	(2.01)	(1.81)	(1.9)
Operating Cash Flow Per Share	(67.83)	(20.8)	(14.91)	(5.73)	(5.16)	(5.42)
Capex To Depreciation	2.59	0.94	6.66	1.34	1.55	1.47
Pb Ratio	0.0291	0.14	0.25	1.57	1.42	1.49
Free Cash Flow Per Share	(69.99)	(21.12)	(16.37)	(5.75)	(5.17)	(5.43)
Roic	(0.31)	(0.52)	(0.94)	(2.67)	(3.07)	(2.92)
Net Income Per Share	(58.24)	(23.66)	(23.2)	(7.65)	(6.89)	(7.23)
Payables Turnover	0.16	0.98	0.0181	0.0409	0.0368	0.0349
Cash Per Share	201.02	42.05	25.49	2.5	2.88	2.73
Pocfratio	(0.0861)	(0.28)	(0.39)	(0.5)	(0.57)	(0.6)
Capex To Operating Cash Flow	(0.0319)	(0.0155)	(0.0984)	(0.003031)	(0.002728)	(0.002865)
Pfcf Ratio	(0.0834)	(0.28)	(0.36)	(0.5)	(0.57)	(0.54)
Days Payables Outstanding	2.3K	370.63	20.1K	8.9K	8.0K	5.7K
Income Quality	1.16	0.88	0.64	0.75	0.86	0.97
Roe	(0.29)	(0.55)	(0.99)	(4.21)	(4.84)	(4.6)
Ev To Operating Cash Flow	0.96	0.14	0.36	(0.28)	(0.26)	(0.27)
Pe Ratio	(0.16)	(0.1)	(0.25)	(0.37)	(0.43)	(0.45)
Return On Tangible Assets	(0.27)	(0.52)	(0.9)	(2.82)	(3.24)	(3.08)
Ev To Free Cash Flow	0.93	0.14	0.32	(0.28)	(0.25)	(0.27)
Earnings Yield	(9.97)	(4.05)	(3.97)	(2.68)	(2.41)	(2.53)
Net Debt To E B I T D A	(3.14)	1.23	0.38	2.24	0.16	0.15
Current Ratio	14.18	16.53	10.72	2.88	2.59	2.46
Tangible Book Value Per Share	200.5	42.94	23.43	1.82	2.09	1.98
Graham Number	512.56	151.18	110.59	17.69	20.34	19.32
Shareholders Equity Per Share	200.5	42.94	23.43	1.82	2.09	1.98
Capex Per Share	2.16	0.32	1.47	0.0174	0.02	0.019
Graham Net Net	186.2	39.37	23.09	1.61	1.85	1.75
Enterprise Value Over E B I T D A	1.13	0.13	1.07	(0.21)	(0.19)	(0.2)
Price Earnings Ratio	(0.16)	(0.1)	(0.25)	(0.37)	(0.43)	(0.45)
Price Book Value Ratio	0.0291	0.14	0.25	1.57	1.42	1.49
Price Earnings To Growth Ratio	(0.001606)	0.004158	0.13	0.005576	0.005019	0.004768
Days Of Payables Outstanding	2.3K	370.63	20.1K	8.9K	8.0K	5.7K
Price To Operating Cash Flows Ratio	(0.0861)	(0.28)	(0.39)	(0.5)	(0.57)	(0.6)
Price To Free Cash Flows Ratio	(0.0834)	(0.28)	(0.36)	(0.5)	(0.57)	(0.54)
Ebt Per Ebit	0.92	1.0	0.98	1.57	1.41	0.86
Effective Tax Rate	0.0195	0.0557	(0.0671)	0.003199	0.003678	0.00395
Company Equity Multiplier	1.07	1.06	1.1	1.49	1.72	1.4

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:

How To Invest In CalciMedica,

Details

Is CalciMedica, Stock a good investment?

Details

What is CalciMedica, Common's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.11)

Return On Assets

(0.65)

Return On Equity

(0.84)

The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

CalciMedica, Historical Financial Ratios

About CalciMedica, Financial Ratios Analysis

CalciMedica, Common Financial Ratios Chart

Ptb Ratio

Book Value Per Share

Payables Turnover

CalciMedica, Common fundamentals Correlations

CalciMedica, Common Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CalciMedica, Common fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Cash Per Share	+ 1.0	Book Value Per Share
Operating Cash Flow Per Share	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Return On Tangible Assets	+ 1.0	Roe

Days Of Inventory On Hand	- 1.0	Inventory Turnover
Pe Ratio	- 0.94	Net Income Per Share
Pocfratio	- 0.94	Inventory Turnover
Return On Tangible Assets	- 0.94	Pb Ratio
Return On Tangible Assets	- 0.94	Ptb Ratio
Pfcf Ratio	- 0.93	Net Income Per Share